Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CTOS | NN |
|---|---|---|
| Price | $9.88 | $13.32 |
| Change today | ▲ 1.02% | ▼ 4.72% |
| Market cap | $2.25B | $2.25B |
| Return, 3 months | +3.2% | -21.1% |
| Return, year to date | +71.5% | -20.0% |
| Return, 1 year | +52.9% | -9.6% |
| P/E (TTM) | 109.8 | -16.2 |
| P/B | 2.8 | 6.7 |
| P/E percentile vs own 5y | 99th | 10th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | -4.3% |
| Net profit growth (YoY) | – | +46.6% |
| Gross margin | – | -104.9% |
| Operating margin | – | -1,900.4% |
| Net margin | – | -2,812.5% |
| Return on equity | – | -77.9% |
| Analyst target vs. price | +31.6% | +72.7% |
| Analyst buy share | 80% | 100% |
| RSI (14) | 59 | 38 |
| 30-day volatility | 35.4% | 60.8% |
| Max drawdown, 1 year | -26.4% | -47.3% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
